Updates and Information on Coronavirus (COVID-19)
Skip to content Skip to main navigation Report an accessibility issue

COVID-19 Funding Opportunities

Information about funding opportunities related to the novel coronavirus (COVID-19) will be added to this page as they become available. Please contact the Associate Vice Chancellor for Research Development (avcrd@utk.edu) for more information or to report additional opportunities.

 

Deadline

Title

Funding Agency

More Information

Continuous submission Artist Relief Americans for the Arts
10/31/20 BAA; No limit to funding BARDA Highly recommended to schedule a TechWatch to brief BARDA POs
Open COVID-19 Collective Fund for Trans Communities Borealis Philanthropy
12/18/20 Emerging Infections Network – Research for Preventing, Detecting, and Managing Travelers who Acquire Infectious Diseases Abroad CDC Please contact Hannah Schmidt at hschmidt@utk.edu if you are interested in applying to this opportunity.
Open Rapid Development of Vaccines Against COVID-19 Coalition for Epidemic Preparedness Initiative (CEPI)
Continuous Submission Public Works and Economic Adjustment Assistance Programs DOC
Continuous Submission Dear Colleague Letter–Coronavirus Disease 2019 (COVID-19) DOE
Rolling Invitation for COVID-19 Scientific Questions DOE
Continuous Submission The COVID-19 High Performance Computing Consortium DOE
Rapid COVID-19 Research at the Spallation Neutron Source and High Flux Isotope Reactor DOE
Open COVID-19 Open Research Dataset Challenge (CORD-19) Kaggle
Rolling COVID-19 Emergency Fund for Journalists National Geographic Society
Rolling Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) NIH
5/8/23 NOSI: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic NIH / NICHD
11/2/20 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR NIH / NIDCR
4/1/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NIH / OBSSR
4/15/21 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NIH / NINDS
4/16/21 NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NIH / NIAAA
4/16/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NIH / NIMH
11/11/20 NOSI: Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NIH / NCATS
7/16/23 NOSI: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract NIH / NICHD
5/1/21 NOSI: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NIH / NIMHD
3/17/21 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) NIH
5/4/21 NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NIH / NIEHS
3/31/21 NOSI: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NIH / NIBIB
2/5/21 NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NIH / NIGMS
3/25/21 NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
Check with PO Administrative Supplements to Existing NIH Grants and Cooperative Agreements; No limit to funding NIH
3/31/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NIH / NIDA
5/1/21 NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NIA
12/30/20 NOSI: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 NIH / NIMH
12/30/20 NOSI: Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations NIH / NIMHD
9/8/22 NOSI: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders NIH / NIDCD
7/2/21 NOSI regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
12/16/20 Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) NIH / NIDDK
7/10/21 NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NIH
11/11/20 NOSI: New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
NIH / NCATS
9/1/21 NOSI: Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 NIH / NIAID
Continuous Submission Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) NIH/DHHS
12/3/20 DCL: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 NSF
N/A Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations OMB
N/A Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset Office of Science and Technology Policy
Rolling Pioneering Ideas: Exploring the Future to Build a Culture of Health Robert Wood Johnson Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.

 

Other Resources

Ubermedia: COVID-19 Impact Research Resources